| 注册
首页|期刊导航|中国药理学与毒理学杂志|灵芝酸A药理作用及其机制研究新进展

灵芝酸A药理作用及其机制研究新进展

谢珍 业康 匡荣 陆静娴 陈碧莲

中国药理学与毒理学杂志2024,Vol.38Issue(8):619-632,14.
中国药理学与毒理学杂志2024,Vol.38Issue(8):619-632,14.DOI:10.3867/j.issn.1000-3002.2024.08.007

灵芝酸A药理作用及其机制研究新进展

New advances in pharmacological effects and mechanisms of ganoderic acid A

谢珍 1业康 2匡荣 1陆静娴 3陈碧莲3

作者信息

  • 1. 浙江省食品药品检验研究院 国家药品监督管理局化妆品动物替代试验技术重点实验室,浙江杭州 310052
  • 2. 浙江省中药研究所有限公司,浙江杭州 310023
  • 3. 浙江省食品药品检验研究院 国家药品监督管理局中成药质量评价重点实验室 浙江杭州 310052
  • 折叠

摘要

Abstract

Ganoderma lucidum is one of the widely-used traditional Chinese medicines.Ganoderma lucidum extract and Ganoderma spore powder are also widely used in foods,health care and cosmetics,and are highly favored by consumers.Ganoderic acid A is one of the main effective components of Ganoderma lucidum triterpenoids.In recent years,a large number of studies have proved that ganoderic acid A has anti-tumor,anti-inflammatory,hepatoprotection,hypolipidemic,renoprotective properties,and has therapeutic potential in psychiatric and neurological disorders.,which has high medicinal value and good prospects for development.Based on review of domestic and foreign literatures in recent years,the new research progress in pharmacology of ganoderic acid A is summarized in this paper in order to provide references for its further development and clinical applications.

关键词

灵芝酸A/药效学/药动学

Key words

ganoderic acid A/pharmacodynamics/pharmacokinetics

分类

医药卫生

引用本文复制引用

谢珍,业康,匡荣,陆静娴,陈碧莲..灵芝酸A药理作用及其机制研究新进展[J].中国药理学与毒理学杂志,2024,38(8):619-632,14.

基金项目

浙江省科技计划项目省级重点研发计划(2021C02019) Key Research and Development Program of Zhejiang Province(2021C02019) (2021C02019)

中国药理学与毒理学杂志

OA北大核心CSTPCD

1000-3002

访问量0
|
下载量0
段落导航相关论文